The activist investor Starboard Value said it would oppose the Bristol-Myers deal on Celgene



[ad_1]

The activist investor Starboard Value announced Thursday its intention to use its stake in Bristol-Myers Squibb to oppose the Celgene acquisition by the drug maker.

Source link